Nuvectis Pharma, Inc.
NVCT
$9.24
$0.819.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.14% | 7.94% | -5.23% | -6.93% | 1.77% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 283.78% | -46.38% | -24.18% | -27.20% | 323.73% |
| Total Current Assets | 62.03% | 7.51% | -5.42% | -7.18% | 2.76% |
|
|
|||||
| Total Current Assets | 62.03% | 7.51% | -5.42% | -7.18% | 2.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 62.03% | 7.51% | -5.42% | -7.18% | 2.76% |
|
|
|||||
| Total Accounts Payable | 19.78% | 10.48% | 22.48% | 4.95% | -36.52% |
| Total Accrued Expenses | -7.72% | 57.73% | 3.34% | -0.23% | -6.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.37% | 40.82% | 9.46% | 1.37% | -18.50% |
|
|
|||||
| Total Current Liabilities | 3.37% | 40.82% | 9.46% | 1.37% | -18.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.37% | 40.82% | 9.46% | 1.37% | -18.50% |
|
|
|||||
| Common Stock & APIC | 19.98% | 6.37% | 3.47% | 4.05% | 9.02% |
| Retained Earnings | -7.28% | -9.33% | -6.61% | -7.58% | -7.69% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 115.73% | -11.63% | -12.27% | -10.65% | 14.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 115.73% | -11.63% | -12.27% | -10.65% | 14.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 115.73% | -11.63% | -12.27% | -10.65% | 14.93% |
|
|
|||||